USE OF HUMAN NEUTROPHIL-LIPOCALINE(HNL) AS DIAGNOSTIC MARKET AND ANTI-HNL ANTI-ANTICORS PRODUCTION

摘要

PCT No. PCT/SE96/00439 Sec. 371 Date Jan. 6, 1997 Sec. 102(e) Date Jan. 6, 1997 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/29404 PCT Pub. Date Nov. 2, 1995Methods of diagnosing human disease comprise measuring a level of human neutrophil lipocalin (HNL) in a sample from an individual human to be diagnosed. A measured value which is higher than the normal level is an indication that the individual suffers from an inflammation.